Thuaire et al.'s review reported BRAF mutations in 7.0% and NRAS mutations in 5.6% of OMM cases, significantly lower than the ~50% and ~30% observed in CM, respectively. The gene discussed is BRAF; the disease is cutaneous mastocytosis.